JPS60195455A - Polymer useful as blood treating agent and molding thereof - Google Patents

Polymer useful as blood treating agent and molding thereof

Info

Publication number
JPS60195455A
JPS60195455A JP59051167A JP5116784A JPS60195455A JP S60195455 A JPS60195455 A JP S60195455A JP 59051167 A JP59051167 A JP 59051167A JP 5116784 A JP5116784 A JP 5116784A JP S60195455 A JPS60195455 A JP S60195455A
Authority
JP
Japan
Prior art keywords
molding
polymer
blood
group
surface area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59051167A
Other languages
Japanese (ja)
Other versions
JPH0585192B2 (en
Inventor
Kazuo Teramoto
和雄 寺本
Mutsuo Murakami
睦夫 村上
Hisanori Shoji
小路 久敬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP59051167A priority Critical patent/JPS60195455A/en
Publication of JPS60195455A publication Critical patent/JPS60195455A/en
Publication of JPH0585192B2 publication Critical patent/JPH0585192B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Abstract

PURPOSE:To remove selectively the cholesterol in blood by a vinyl polymer having the arom. nucleus into which the functional group expressed by the specific formula is incorporated as a side chain and the molding thereof. CONSTITUTION:A vinyl polymer having the arom. nucleus into which the functional group expressed by the formula is incorporated as a side chain and the molding thereof constitute a blood treating agent. The result is much better if the polymer is crosslinked and if the polymer is reinforced by poly alpha-olefin as represented by crystalline PP or PE as the mechanical strength is improved with the latter. The immobilizing density decreases if the surface area is too small in the case of the molding but if the surface area is too large, the liquid passability of the column in which the molding is packed decreases and therefore the preferable surface area is 0.01-50m<2>/g.

Description

【発明の詳細な説明】 〔発明の技術分野〕 本発明は、血液中のコレステロール等脂質を特異的に吸
着する血液処理剤として有用なm合体およびその成型品
に関する。
DETAILED DESCRIPTION OF THE INVENTION [Technical Field of the Invention] The present invention relates to an m-combination useful as a blood treatment agent that specifically adsorbs lipids such as cholesterol in blood and molded products thereof.

(従来技術とその問題点) 血液中のコレステロールは、元来、生命維持に必要なも
のであるが、多すぎると動脈硬化を促進し、脳卒中や心
筋梗塞の発作に導くものであり、また、その■が急激に
多くなる高脂血症では急死することがある。血液中にお
(プるコレステロールはグロブリンタンパク質と結合し
、リポタンパク質として存在する。このリポタンパク質
を選択的に除去することは、高価な免疫学的手法を用い
ない限り、非常に困難である。
(Prior art and its problems) Cholesterol in the blood is originally necessary for life support, but too much cholesterol promotes arteriosclerosis, leading to strokes and myocardial infarctions. Hyperlipidemia, where ■ increases rapidly, can lead to sudden death. Cholesterol in the blood is bound to globulin proteins and exists as lipoproteins. It is extremely difficult to selectively remove these lipoproteins without using expensive immunological techniques.

(発明の目的) 本発明者らは臨床分析や治療に用いることが可能な、血
液中のコレステロールを選択的に除去する吸着剤を見い
出すべく鋭意検討した結果、本発明に到達した。
(Object of the Invention) The present inventors have arrived at the present invention as a result of intensive studies to find an adsorbent that selectively removes cholesterol in blood, which can be used for clinical analysis and treatment.

〔発明の構成〕[Structure of the invention]

即ち、本発明は側鎖として、下記一般式(1)で示され
る官能基を導入した芳香核を有するビ二ル系重合体およ
びその成型品。
That is, the present invention relates to a vinyl polymer having an aromatic nucleus into which a functional group represented by the following general formula (1) is introduced as a side chain, and a molded product thereof.

上式中、R1は10個以上のメチレン鎖長を有1Jるア
ルキル基を示し、R2およびR3はメチル基、エヂル基
またはn−プロピル基を示η。また、R4およびR5は
水素原子J:たは低級アルキル基を示で。Xは塩素イオ
ンで代表される通常の陰イAンを示ず。
In the above formula, R1 represents a 1J alkyl group having a methylene chain length of 10 or more, and R2 and R3 represent a methyl group, an ethyl group, or an n-propyl group. Further, R4 and R5 represent a hydrogen atom or a lower alkyl group. X does not represent the usual anion A represented by chlorine ion.

を提供づるものである。It is intended to provide the following.

(効果の要約) 本発明の重合体およびその成型品は、血液、血漿または
血清中のコレステロールを選択的に吸着除去できる。こ
のことにより高脂血症、高]レステ[1−脂血症の治療
に使用できる可能性がある。
(Summary of Effects) The polymer of the present invention and its molded product can selectively adsorb and remove cholesterol in blood, plasma, or serum. Accordingly, it may be used for the treatment of hyperlipidemia, hyper]leste[1-lipidemia.

〔構成および効果の説明〕[Explanation of composition and effects]

本発明でいう芳香核を有するビニル系重合体とはスヂレ
ン、α−メヂルスチレン、ビニルトルエンなどで代表さ
れる芳香核を有するビニル系モノマの単独重合体もしく
はこれらを1刃戊分とηる1m合体を意味し、これらの
手合体IJ架橋されCいればさらに好ましい。また該重
合体は結晶171ポリプロピレン、ボリエチレンなどで
代表されるポリα−オレフィンで補強されていれば、機
械的性質が向」−するので、さらに好ましい。例えば、
ジビニルベンゼンあるいはメチレンビスアクリルアミド
等で代表されるポリビニル化合物とのJtffi合体の
ほか、上記モノビニル化合物重合体成形品をホルムアル
デヒド、クロルスルホン酸等で架橋処理したもの等があ
げられる。架橋中合体は流動性がなく、成形が困辣イT
ので、該重合体成形品がlJi Ml、膜等の場合は成
形後架橋処理する方法が好ましく採用される。
In the present invention, the vinyl polymer having an aromatic nucleus is a homopolymer of a vinyl monomer having an aromatic nucleus such as styrene, α-methylstyrene, vinyltoluene, etc., or a 1 m aggregation of these monomers with 1 blade. It is more preferable if these hand-combined IJ crosslinks. Further, it is more preferable that the polymer is reinforced with a poly-α-olefin such as crystal 171 polypropylene or polyethylene, since the mechanical properties will be improved. for example,
In addition to Jtffi combinations with polyvinyl compounds typified by divinylbenzene or methylenebisacrylamide, examples include those obtained by crosslinking the above-mentioned monovinyl compound polymer molded products with formaldehyde, chlorosulfonic acid, etc. Coalescing during crosslinking has no fluidity and is difficult to mold.
Therefore, when the polymer molded article is lJi Ml, a membrane, etc., a method of crosslinking after molding is preferably employed.

上記一般式(1)中、アルキルM R1のメチレン鎖長
は長い稈コレステロール等脂質との親和11は良いが、
メチレン鎖長が24個以上のものは原料が入手しにくい
。このアルキルも!は枝分かれしていてもよいが、原I
Iが入手lノにくい。R2およびR3のアルキル基は炭
素数が多いと本発明手合体の疎水性が高くなり寸きるの
で、最も炭素数の少ないメチル基が最良である。R4お
よびR5のアルキル基は水素原子である場合が最もl!
J造しやすい。
In the above general formula (1), the methylene chain length of alkyl M R1 is long, and it has good affinity with lipids such as cholesterol (11), but
Raw materials for those with a methylene chain length of 24 or more are difficult to obtain. This alkyl too! may be branched, but the original I
It is difficult to obtain I. If the alkyl group of R2 and R3 has a large number of carbon atoms, the hydrophobicity of the polymer of the present invention will become high, so a methyl group having the smallest number of carbon atoms is best. The alkyl groups of R4 and R5 are most often hydrogen atoms!
Easy to build.

本発明成形品の表面積はあまり小さすぎると、固定化密
度が低くなるが、あまり大ぎすぎても、本発明成形品を
充1眞したカラムの通液性が悪くなるので、該成形品の
表面積は0.01以上50m’7・′Q以下、より好ま
しくは0.05以上10m’/Q以下がよい。
If the surface area of the molded article of the present invention is too small, the immobilization density will be low, but if it is too large, the liquid permeability of the column filled with the molded article of the present invention will be poor. The surface area is preferably 0.01 or more and 50 m'7·'Q or less, more preferably 0.05 or more and 10 m'/Q or less.

本発明重合体中の上記一般式(1)で示される官能基の
出に(ユ特に限定はないが、少なずぎると本発明重合体
おJ、びその成型品と血液との親和性が悪くなるので、
該重合体1Qあたり0.2ミリモル以上、より好ましく
は1.0ミリモル以上存在するのがよい。また、本発明
重合体中に芳香核側鎖として、一般式(1)で表わされ
る官能基の他に、一般式(2)で表わされる官能基が存
在すると、5− / I R81( 上式中、Re、R7、R8は低級アル髪ル基を示し、か
つ、それらの炭素数の和が12以下である組合Iの基を
示す。
There is no particular limitation on the amount of functional groups represented by the above general formula (1) in the polymer of the present invention (although there is no particular limitation), if the amount is too small, the affinity of the polymer of the present invention and its molded products with blood will deteriorate. So,
The amount is preferably 0.2 mmol or more, more preferably 1.0 mmol or more per 1Q of the polymer. Furthermore, when a functional group represented by the general formula (2) is present as an aromatic nucleus side chain in the polymer of the present invention in addition to the functional group represented by the general formula (1), 5-/I R81 (the above formula Among them, Re, R7, and R8 represent a lower alkyl group, and represent a group of combination I in which the sum of their carbon numbers is 12 or less.

一般式(1)で表わされる官能基の数が少4【<ても本
発明重合体およびその成型品と血液との親和性が悪くな
らないので好ましい。官能)i↓(1)と官能基(2)
が共存する場合は官能基(1)はR重合体1Ωあたり0
.01ミリモル以上存在するのがよく、かつ両官能基の
肌の和が、1.0ミリモル以上存在づるのがよい。
Even if the number of functional groups represented by the general formula (1) is small, it is preferable because the affinity of the polymer of the present invention and its molded product with blood will not deteriorate. Functional) i↓ (1) and functional group (2)
When coexisting, the functional group (1) is 0 per 1Ω of R polymer.
.. It is preferable that the amount is 0.1 mmol or more, and the sum of both functional groups is preferably 1.0 mmol or more.

本発明重合体およびモの成型品の製造は、α−ハロアセ
トアミドメチル化芳香族ビニル系重合体く特開昭57−
12008>および子の成型品を一般式(3)で表わさ
れるアミンの溶液に浸漬することにより、あるいは、上
記アミンと一般式(4)で表わされるアミンとの混合溶
液に浸漬することにより達成できる。
The polymer of the present invention and the molded product thereof can be produced by using α-haloacetamidomethylated aromatic vinyl polymer.
12008> and a child molded product by immersing it in a solution of an amine represented by general formula (3), or by immersing it in a mixed solution of the above amine and an amine represented by general formula (4). .

6一 R1−N−R2 1 R3・・・・・・(3) Pa−N−Ra ■ R7・・・・・・(4) 以下に実施例を示す 実施例1 ボリプ[1ピレン(三井゛′ノーブレン′”J 3 H
G )50部を島成分どし、ボリスヂレン〈゛′スタイ
ロン”666)/16部、ポリプロピレン(住友゛′ノ
ーブレン″’WF−727−F)4部の混合物を海成分
とする海、鵬型複合砿腑(、@数16、単糸繊度2.6
デニール、引張強度2.9a/d、伸度50%、フィラ
メント数42)100Gを、N−メ′f−1=1−ルー
α−クロルアセ]・アミド1209、ニトロベンゼン8
00g、98%硫酸aoogおよびパラホルムアルデヒ
ド1.70からなる混合溶液中に浸し、20℃で1時間
反応させた。繊維を反応液から取り出し、0℃の氷水1
00中に投じて、反応停止させたのち、水で洗かし、次
に、繊維に付着しているニトロベンゼンをメタノールで
抽出除去した。この11維(繊MA)を50’Cで真空
乾燥して、クロルアセトアミトメプル化41E H14
09を1qた。
6-R1-N-R2 1 R3 (3) Pa-N-Ra ■ R7 (4) Example 1 Volip [1 Pyrene (Mitsui) 'Noblen'” J 3 H
G) Sea, Peng-type composite with a mixture of 50 parts of island component, 16 parts of Boris Dilene ('Styron' 666), and 4 parts of polypropylene (Sumitomo 'Noblen'' WF-727-F) as sea component.砿腑(,@number 16, single yarn fineness 2.6
Denier, tensile strength 2.9a/d, elongation 50%, number of filaments 42) 100G,
00 g, 98% sulfuric acid aoog, and paraformaldehyde 1.70 g, and reacted at 20° C. for 1 hour. Take out the fibers from the reaction solution and add them to ice water at 0°C.
After the reaction was stopped, the fibers were washed with water, and the nitrobenzene adhering to the fibers was extracted and removed with methanol. These 11 fibers (fiber MA) were vacuum-dried at 50'C to form 41E H14
I got 1q of 09.

上記で(qた1lIftA100gを10017)aつ
化カリウムを含む10%含水Tタノール2Qに浸し、5
0℃で4時間加熱して、三j−ドアセ1−アミトメデル
化繊紹<m維B)を得た。
Soak 100g of the above (100g of 1lIftA in 2Q of 10% water-containing T-tanol containing potassium acetate),
The mixture was heated at 0° C. for 4 hours to obtain 3-j-doacetic acid 1-amitomedel fiber B).

m1ftB100をN、N−ジメチルスデアリルアミン
20Q、ジメチルホルムアミド28o1およびエタノー
ル50m1からなる溶液に浸し、70”Cで14詩間加
熱した。ざらに、この綴紐を、ソックスレー抽出器で、
10時間メタノール抽出したのら、クロマトカラムにつ
め、1aのIN−Jg酎、5f2(7)水、1 [(7
)I N−カセイソー’l水、5Qの水および100の
1 M −食塩水で、順次、洗浄して、塩化N、N−ジ
メヂルーN−スデアリルアンモニウムアしドアミドメチ
ル化繊麗〈木発明試わ11)を(qた。このものは、中
性塩分解合■が0.73ミU当吊/9、弱塩基竹is 
inが0.03ミリ当ffi/Qで、C1型含水度は0
.47であった。
mlftB100 was immersed in a solution consisting of 20Q N,N-dimethylsudearylamine, 28o1 dimethylformamide and 50ml ethanol and heated at 70"C for 14 hours. Roughly, the string was soaked in a Soxhlet extractor.
After methanol extraction for 10 hours, it was packed into a chromatography column and mixed with IN-Jg 1a, 5f2(7) water, 1[(7
)I N-Caussio'l water, 5Q water and 100 parts of 1M saline solution, washed sequentially to prepare N,N-dimedylene chloride, N-sudearylammonium acidamide methyl synthetic fiber (wooden invention trial). 11) (q. This thing has a neutral salt decomposition ratio of 0.73 μU/9, a weak base bamboo is
in is 0.03 mmffi/Q, and the water content of type C1 is 0.
.. It was 47.

実施例2 実施例1で1ηた繊It B 10 aをN、N−ジメ
ヂルラウリルアミン200および、ジメチルホルムアミ
ド180Qの混合溶液に浸し、80℃で5時間加熱した
。このIM Mをソックスレー抽出器で、10時間メタ
ノール抽出したのち、クロマトカラムにつめ、1Qの1
N−塩酸、5aの水、10の1N−カセイソーダ水、5
Qの水および1072の1M−食塩水で洗浄して、塩化
N、N−ジメチルーN−ラウリルアンモニウムアセトア
ミドメチル化繊紐〈本発明試料2)を(りた。このもの
は、中性用分解容■が0.73ミリ当ffi/Gで、弱
塩基は<’K <、C1型含水度は0.71であった。
Example 2 The fiber It B 10a, which had been prepared by 1η in Example 1, was immersed in a mixed solution of N,N-dimethyllaurylamine 200 and dimethylformamide 180Q, and heated at 80° C. for 5 hours. This IMM was extracted with methanol for 10 hours using a Soxhlet extractor, and then packed into a chromatography column and
N-hydrochloric acid, 5a water, 10 1N-caustic soda water, 5
The N,N-dimethyl chloride-N-lauryl ammonium acetamidomethyl synthetic fiber string (Sample 2 of the present invention) was washed with water of Q and 1M saline solution of 1072. was 0.73 mm/ffi/G, the weak base was <'K<, and the C1 type water content was 0.71.

実施例3 本発明試料1、本発明試料2および比較試料1おJ:び
2について、以下の吸着試験を行なった。
Example 3 The following adsorption test was conducted on Inventive Sample 1, Inventive Sample 2, and Comparative Samples 1, J: and 2.

ヒト血R101+11に試n200mgを加え、37℃
で3時間振とうしたのら、上澄みについて血液成分の■
を調べ、各成分に対する眼精率をめた。
Add 200mg of sample to human blood R101+11 and heat at 37°C.
After shaking for 3 hours, the supernatant was examined for blood components.
were investigated, and the eye sperm rate for each component was determined.

−〇− 結果を表1に示す。但し、I−I D L−コレステロ
ールはヘパリンマンガン・沈澱酵素法でめた。
-〇- The results are shown in Table 1. However, I-ID L-cholesterol was determined by the heparin-manganese precipitated enzyme method.

表 1 但し、比較試料1および2は実施例1のN、N−ジメヂ
ルステアリルアミンの代りに、1ヘリn−ブヂルアミン
およびトリn−オクチルアミンを用いる他は実施例1と
全く同様に処理してv4製したものである。比較試料1
(トリn−ブチルアンモ10− ニウムアセ1〜アミドメチル化繊lt>は中性塩分解室
ff11.54ミリ当量/Q、弱塩基性暴行io、。
Table 1 However, comparative samples 1 and 2 were treated in exactly the same manner as in Example 1, except that 1-helical n-butylamine and tri-n-octylamine were used instead of N,N-dimethylstearylamine in Example 1. It was made using v4. Comparison sample 1
(Tri n-butylammonium 10-nium ace1-amide methyl synthetic fiber lt> is a neutral salt decomposition chamber ff 11.54 milliequivalents/Q, a weak base attack io,

3ミリ当ff110.CI型含水度1.54であった。3mm per ff110. The CI type water content was 1.54.

比較試料2(トリn−オクチルアンモニウムアセトアミ
トメデル化IJIff)は中性塩分貯容ff10.61
ミリ当fIl/gで、弱塩基性基間はなく、C1型含水
度は0.46であった。
Comparative sample 2 (tri n-octylammonium acetamitomedelated IJIff) has a neutral salt storage ff10.61
There was no weakly basic group, and the water content of C1 type was 0.46.

表1から、本発明試料1.2は有用なタンパク質成分を
吸着することなく、トIDL−コレステロールのみを選
択的に吸着することがわかる。一方、比較試料1.2は
、その官能基が炭素数において、本発明試料とほとんど
かわらないにもかかわらず、1−I D L−コレステ
ロールを全く吸着することがない。即ち、本発明試料の
特異的吸着能は、その特殊な官能基の構造に由来したも
のであることがわかる。
Table 1 shows that sample 1.2 of the present invention selectively adsorbs only IDL-cholesterol without adsorbing any useful protein components. On the other hand, Comparative Sample 1.2 does not adsorb 1-ID L-cholesterol at all, even though its functional group has almost the same number of carbon atoms as the sample of the present invention. That is, it can be seen that the specific adsorption ability of the sample of the present invention is derived from the structure of its special functional group.

特許出願人 東 し 株 式 会 社 11− AQ−Patent applicant Higashi Shikikai Co., Ltd. 11- AQ-

Claims (1)

【特許請求の範囲】 側鎖どして、下記一般式(1)で示される官能基を導入
した芳香核を有するビニル系重合体およびその成型品。 / I R31」 上式中、R1は10個以上のメチレン鎖長を有するアル
キル基を示し、R2およびR3はメチル基、エチル基ま
たはn−プロピル基を示す。また、R4およびR5は水
素原子または低級アルキル基を示す。Xは塩素イオンで
代表される通常の陰イオンを示す。
[Scope of Claims] A vinyl polymer having an aromatic nucleus into which a functional group represented by the following general formula (1) is introduced as a side chain, and a molded product thereof. /I R31'' In the above formula, R1 represents an alkyl group having a methylene chain length of 10 or more, and R2 and R3 represent a methyl group, an ethyl group, or an n-propyl group. Further, R4 and R5 represent a hydrogen atom or a lower alkyl group. X represents a normal anion represented by a chlorine ion.
JP59051167A 1984-03-19 1984-03-19 Polymer useful as blood treating agent and molding thereof Granted JPS60195455A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59051167A JPS60195455A (en) 1984-03-19 1984-03-19 Polymer useful as blood treating agent and molding thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59051167A JPS60195455A (en) 1984-03-19 1984-03-19 Polymer useful as blood treating agent and molding thereof

Publications (2)

Publication Number Publication Date
JPS60195455A true JPS60195455A (en) 1985-10-03
JPH0585192B2 JPH0585192B2 (en) 1993-12-06

Family

ID=12879263

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59051167A Granted JPS60195455A (en) 1984-03-19 1984-03-19 Polymer useful as blood treating agent and molding thereof

Country Status (1)

Country Link
JP (1) JPS60195455A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6383500B1 (en) * 1996-06-27 2002-05-07 Washington University Particles comprising amphiphilic copolymers, having a crosslinked shell domain and an interior core domain, useful for pharmaceutical and other applications
WO2003101511A1 (en) 2002-05-30 2003-12-11 Toray Industries, Inc. Immunosuppressive substance adsorbent, extracorporeal circulation column and method of treating cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0312900A (en) * 1989-06-10 1991-01-21 Samsung Electron Co Ltd Recording circuit for testing ram

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0312900A (en) * 1989-06-10 1991-01-21 Samsung Electron Co Ltd Recording circuit for testing ram

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6383500B1 (en) * 1996-06-27 2002-05-07 Washington University Particles comprising amphiphilic copolymers, having a crosslinked shell domain and an interior core domain, useful for pharmaceutical and other applications
US6491903B1 (en) * 1996-06-27 2002-12-10 Washington University Particles comprising amphiphilic copolymers
WO2003101511A1 (en) 2002-05-30 2003-12-11 Toray Industries, Inc. Immunosuppressive substance adsorbent, extracorporeal circulation column and method of treating cancer

Also Published As

Publication number Publication date
JPH0585192B2 (en) 1993-12-06

Similar Documents

Publication Publication Date Title
Puchtler et al. Methacarn (methanol-Carnoy) fixation: practical and theoretical considerations
CA1073815A (en) Method for purification and isolation of hepatitis virus for use in the preparation of vaccine
US5679776A (en) Process for preparing a concentrate of blood coagulation factor VIII-von willebrand factor complex from total plasma
DE2319495A1 (en) PROCESS FOR SELECTIVE AND REVERSIBLE BINDING OF BIOMOLECULES TO ADSORBENTS
Puchtler et al. Silver impregnation methods for reticulum fibers and reticulin: A re-investigation of their origins and specifity
JPH06502848A (en) Imidoester crosslinked hemoglobin composition
JPS60195455A (en) Polymer useful as blood treating agent and molding thereof
Huisman et al. Studies on animal hemoglobins II. The influence of inorganic phosphate on the physico-chemical and physiological properties of the hemoglobin of the adult chicken
DE3013724A1 (en) NEW PROTEIN PP (DOWN ARROW) 9 (DOWN ARROW), METHOD FOR ITS ENRICHMENT AND PRODUCTION AND ITS USE
US4386006A (en) Ion-exchange compositions
Yavuz et al. Dye affinity hollow fibers for albumin purification
Hinson et al. A rapid method for preparing crystalline human hemoglobin and the separation of crystalline hemoglobin A in quantity
US4350767A (en) Method for isolating and purifying enzymes from a crude enzyme solution
GB2053926A (en) Albumin extraction by affinity chromatography
CN109174022B (en) Method for immobilizing adsorption material for blood purification
Yihua et al. A new low density lipoprotein (LDL) adsorbent
DE4337573C1 (en) Process for the preparation of a virus-inactivated factor VIII-containing fraction by means of chromatographic methods
Benabid et al. Soluble fibrin complexes: separation as a function of pH and characterization
CH626263A5 (en)
DE3014632C2 (en)
DE2709500C2 (en) Method for purifying heparin
RU2094117C1 (en) Sorbent and method for its production
RU2174130C1 (en) Method of modifying cellulose acetates for preparing films, membranes and biofilters
Vadlamudi et al. Differential solubilization of human erythrocyte cell membrane proteins by maleic anhydride
Aleyamma et al. Poly (vinyl alcohol)-polyelectrolyte blended membranes-blood compatibility and permeability properties